GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Annual Report to Security Holders
Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Other Events, Press Release
Daniel Bendheim Appointed CEO and President of Phibro Animal Health
Reports Third Quarter Results, Updates Financial Guidance
Declares Quarterly Dividend
Phibro Animal Health Corporation Increases Credit Facility by $125 Million
Announces Regulatory Framework Change in Brazil for Antimicrobials
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Amended Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Confidential Treatment Order
Submission Upload